CoChat

Induction of Therapeutic Senescence in Vemurafenib-Resistant Melanoma by Extended Inhibition of CDK4/6

Open access
Yoshida, Akihiro, Lee, Eric K., Diehl, J. Alan · 2016 · Cancer Research

Published version of a preprint

The DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.

Abstract

Dysregulation of the p16-cyclin D1-CDK4/6-Rb pathway occurs frequently in melanoma; however, the therapeutic efficacy of CDK4/6 inhibition remains to be critically evaluated. We demonstrate that CDK4/6 inhibition inhibits melanoma progression through induction of senescence. Palbociclib, a specific CDK4/6 inhibitor, rapidly induces cell cycle arrest within 24 hours and continued exposure for 8 days or longer induces senescence. The induction of senescence correlates with inhibition of mTOR and more specifically mTORC1 signaling. Vemurafenib, a specific BRAF(V600E) inhibitor, has significant clinical efficacy in BRAF(V600E)-positive melanomas, but its impact is hampered by a rapid acquisition of resistance. Strikingly, we found that vemurafenib-resistant tumors remain sensitive to palbociclib, suggesting that initial treatment with vemurafenib followed by palbociclib with or without mTOR inhibitors might provide an avenue to overcome recurrence of vemurafenib-resistant metastatic disease. Taken together, these results support palbociclib as a promising therapeutic for treatment of melanoma. Cancer Res; 76(10); 2990-3002. ©2016 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-15-2931

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Cited by

See all 161

Metadata

Authors
Yoshida, A., Lee, E. K., & Diehl, J. A.
Affiliations
  • Medical University of South Carolina (US)
  • University of Michigan (US)
Corresponding author
Diehl, J. Alan
Venue
Cancer Research
Published
2016-05-12
Volume
76
Issue
10
Pages
2990-3002
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2300472255
Cited by
153
References
45
Citations by year
2026: 5 · 2025: 10 · 2024: 11 · 2023: 15 · 2022: 23 · 2021: 16 · 2020: 25 · 2019: 13 · 2018: 17 · 2017: 15 · 2016: 3
FWCI
8.32
Type
journal article
Language
en
Open access
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Cancer Institute (P01CA098101, R01CA133154)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
  • Health Sciences › Medicine › Oncology › Advanced Breast Cancer Therapies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
Keywords
melanoma, vemurafenib resistance, CDK4/6 inhibition, palbociclib, senescence, mTORC1 signaling, BRAF V600E mutation, cell cycle arrest, combination therapy, metastatic melanoma
MeSH terms
Vemurafenib, Animals, Flow Cytometry, Fluorescent Antibody Technique, Humans, Immunoenzyme Techniques, Indoles, Melanoma, Mutation, Piperazines, Pyridines, RNA, Messenger, Sulfonamides, Tumor Cells, Cultured, Blotting, Western, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Mice, SCID, Cellular Senescence, Apoptosis, Drug Resistance, Neoplasm, Reverse Transcriptase Polymerase Chain Reaction, Xenograft Model Antitumor Assays, Protein Kinase Inhibitors, Proto-Oncogene Proteins B-raf, Cell Proliferation, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6, Mice, Real-Time Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Induction of Therapeutic Senescence in Vemurafenib-Resistant Melanoma by Extended Inhibition of CDK4/6. https://app.cochat.ai/papers/10.1158/0008-5472.can-15-2931
The paper
Yoshida, A., Lee, E. K., & Diehl, J. A. (2016). Induction of Therapeutic Senescence in Vemurafenib-Resistant Melanoma by Extended Inhibition of CDK4/6. Cancer Research. https://doi.org/10.1158/0008-5472.can-15-2931

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.